EOLS
Evolus, Inc. Common Stock
stockNASDAQ
At CloseOct 2, 2026 4:00:00 PM EDT
7.14USD-7.152%(-0.55)2,070,873
Pre-marketOct 2, 2026 9:27:30 AM EDT
7.69USD0.000%(0.00)
Loading…
Loading…
472.59M
Healthcare
Drug Manufacturers-Specialty & Generic
CEO
David Moatazedi
HQ
Newport Beach, CA, USA
Previous Close
$7.69
Beta
1.07
52-Week High
$9.31 2026-09-04
52-Week Low
$3.86 2026-03-30
SMA 50
$7.85
SMA 200
$6.16
Avg. Vol 10D
660,982
Avg. Vol 30D
888,979
Avg. Vol 90D
865,362
Relative Vol
2.33
66.05M
50.04M
75.76%
5,530,759
11.05%
6.60
61%/39%
69.74%
47.91%
0.4100%
6,900,000
1,884
1,094
2,943
Nov 4, 2026 (30d)
Oct 2, 2026
Evolus drops as FDA says Jeuveau Instagram post is misleading · 
Seeking Alpha
Sep 28, 2026
Add Up The Pieces: IHE Could Be Worth $116 · 
BNK Invest
EOLS Profile
evolus, inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the united states. it offers jeuveau, a proprietary 900 kilodalton purified botulinum toxin type a formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. the company was founded in 2012 and is headquartered in newport beach, california.
EOLS Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 7.96 | 2026-09-28 | -10.11% | -8.008 |
| 1M | 9.30 | 2026-09-04 | -23.07% | 0.907 |
| 3M | 6.99 | 2026-07-06 | +2.36% | 0.381 |
| 6M | 4.16 | 2026-04-06 | +72.00% | 0.430 |
| 1Y | 6.50 | 2025-10-03 | +10.08% | 1.069 |
| 2Y | 16.34 | 2024-10-04 | -56.21% | — |
| 5Y | 7.53 | 2021-10-04 | -4.98% | 1.044 |
EOLS Stock Summary
Evolus, Inc. Common Stock (NASDAQ:EOLS) stock price today is $7.16, and today's volume is 2,070,873. EOLS is down 6.957% today. The 30 day average volume is 888,979. EOLS market cap is $472.59M with 66.05M shares outstanding.